Characteristics | Total (n = 122) | CLNM + (n = 60) | CLNM - (n = 62) | P Value |
---|---|---|---|---|
Gender (M/F) | 60/62 | 44/16 | 16/46 | 0.015a |
Age ± SD (years) | 48 ± 11 | 46 ± 10 | 50 ± 11 | 0.044a,b |
≥45/<45 | 83/39 | 37/23 | 46/16 | 0.138 |
≥50/<50 | 57/65 | 21/39 | 36/26 | 0.011a |
Tumor size ± SD (mm) | 6.5 ± 2.6 | 7.2 ± 2.3 | 5.8 ± 2.7 | 0.002a,b |
≥5/<5 | 95/27 | 51/9 | 44/18 | 0.062 |
≥7/<7 | 59/63 | 36/24 | 23/39 | 0.011a |
Multifocality (%) | 19 (15.6) | 14 (23.3) | 5 (8.1) | 0.020a |
ETE (%) | 7 (5.7) | 5 (8.3) | 2 (3.2) | 0.269c |
T stage (T1/2:T3/4) | 115/7 | 55/5 | 60/2 | 0.269c |
With HT (%) | 43 (35.2) | 19 (31.7) | 24 (38.7) | 0.416 |
Bilateral PTMC (%) | 60 (50.8) | 26 (61.9) | 34 (42.5) | 0.042a |
Preoperative tumor size (mm) | 6.8 ± 2.8 | 7.5 ± 2.6 | 6.1 ± 2.9 | 0.008a |
≥5/<5 | 99/23 | 52/8 | 47/15 | 0.125 |
≥7/<7 | 61/61 | 37/23 | 24/38 | 0.001a |
Preoperative multifocality (%) | 16(13.1) | 12(20.0) | 4(6.6) | 0.027a |